ERCC8-AS1 and RDH10-AS1 were markedly upregulated in osteosarcoma tissues, which may serve as biomarkers for osteosarcoma and potential therapeutic targets (Rothzerg et al. 2021). Here, RDH10 is linked to osteosarcoma.